logo-loader

Medlab Clinical chief updates on progress with NanaBis and NRG Biotic

Published: 23:03 11 Mar 2019 EDT

Medlab Clinical Ltd (ASX:MDC) managing director & CEO Sean Hall visits Proactive's Sydney studio following participation at the Australian Pharmacy Professional Conference & Trade Exhibition (APP2019).

Hall updates on the progress of clinical trials for NRGBiotic™, a nutraceutical already available in pharmacies.

He also discusses a recent heads of agreement (HoA) reached with Canadian pharmaceutical company Pharmascience Inc. for the further development and global distribution of NanaBis™, which is also progressing through clinical trials.

Xeris Biopharma Surpasses 2023 Expectations with Strategic Moves Poised for...

Xeris Biopharma CEO Paul Edick joined Steve Darling from Proactive to share news the company had a successful 2023, with a final tally of 164 million USD, which is at the upper end of their forecast. The company concluded the year with 72 million USD in cash, surpassing their initial projections...

7 hours, 43 minutes ago